Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02855580 · ClinicalTrials.gov registry record

Integrating Pharmacogenomic Testing Into a Child Psychiatry Clinic

A clinical trial of Anxiety and Major Depressive Disorder, sponsored by University of Florida.

Completed
Registry status
71
Enrollment target
1
Study location

NCT02855580 is a study of Anxiety and Major Depressive Disorder that has completed, run by University of Florida. The registered enrollment target is 71 participants, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02855580, a study of Anxiety and Major Depressive Disorder, has completed, sponsored by University of Florida.

COMPLETED
Registry status
71 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to examine the feasibility, acceptability, and utility of pharmacogenomic (PGX) testing (specifically for the cytochrome P450 2D6 and 2C19 genes) prior to initiating treatment with an antidepressant (AD) among children and adolescents in the University of Florida Child Psychiatry clinics.

Study Locations (1)

Florida

  • Child Psychiatry Clinic at University of Florida - Gainesville

Trial Details

FieldValue
Enrollment Target 71 participants
Start Date 2016-09
Est. Completion 2017-07-06

Sponsor

University of Florida

1,106 total trials

What the Registry Record Tells You About NCT02855580

The ClinicalTrials.gov registry entry for NCT02855580 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 71 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 364 other Anxiety trials with a reported enrollment target (84% lower). The listed sponsor is University of Florida, which has 1,106 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Anxiety appearing as the primary indexed condition, and to 0 interventions.

NCT02855580 reports 1 study location spanning 1 distinct geographic area - top geographies include Florida.

Frequently Asked Questions

What is clinical trial NCT02855580 about?

NCT02855580 is a clinical study titled "Integrating Pharmacogenomic Testing Into a Child Psychiatry Clinic". The purpose of this study is to examine the feasibility, acceptability, and utility of pharmacogenomic (PGX) testing (specifically for the cytochrome P450 2D6 and 2C19 genes) prior to initiating treatment with an antidepressant (AD) among children and adolescents in the University of Florida Child P...

What is the current status of trial NCT02855580?

This trial is currently completed. The enrollment target is 71 participants. The study started on 2016-09. Estimated completion is 2017-07-06.

What conditions does trial NCT02855580 study?

This clinical trial studies the following conditions: Anxiety, Major Depressive Disorder, Obsessive - Compulsive Disorder.

Who is sponsoring clinical trial NCT02855580?

This trial is sponsored by University of Florida, which has 1,106 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02855580 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anxiety

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.